Back

Instantaneous Wave-Free Ratio-Guided vs Angiography-Guided Coronary Artery Bypass Grafting: 36-Months Graft Patency and Clinical Outcomes of a Randomized Trial

Ordiene, R.; Unikas, R.; Benetis, R.; Jakuska, P.; Ciaponiene, I.; Ivanauskiene, A.; Jankauskas, A.; Aldujeli, A.; Plisiene, J.; Kabosis, T.; Punjabi, P. P.; Davies, J. E.; Krivickas, Z.

2026-04-03 cardiovascular medicine
10.64898/2026.04.01.26350013 medRxiv
Show abstract

Background: Coronary artery bypass grafting (CABG) to physiologically non-significant coronary artery stenosis may result in graft failure due to competitive native flow. We evaluated whether an instantaneous wave-free ratio (iFR)-guided revascularization strategy improves graft patency and clinical outcomes compared to conventional angiography-guided CABG. Methods: In this prospective, randomized, single-blinded trial, patients with multivessel disease and at least one angiographically intermediate stenosis (50%-75%) were randomized to either CABG guided by angiography alone or angiography supplemented with iFR assessment groups. The primary endpoint was graft patency (occlusion or hypoperfusion of the graft) evaluated by coronary computed tomography angiography (CCTA) at 2, 12, and 36 months. Results: At 36 months, 78% of the patients completed follow-up. Left internal mammary artery (LIMA)-to-left anterior descending (LAD) artery graft patency was significantly higher in the iFR-guided group than in the angiography-guided group (80.5% vs. 56.8%; absolute risk difference, 23.7% [95% CI, 3.7%-43.8%]; RR, 1.42 [95% CI, 1.03-1.95]; P = 0.03). Saphenous vein graft patency also improved with iFR guidance (90.2% vs. 70.3%; P = 0.046). Major adverse cardiac and cerebrovascular events (MACCE) were similar between groups (28% vs. 20%; RR, 1.40 [95% CI, 0.69-2.85]; P = 0.48). Conclusions: iFR-guided CABG advocates significantly improved mid-term graft patency compared with angiography-guided CABG by optimizing surgical target selection and reducing competitive flow.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Circulation
66 papers in training set
Top 0.1%
18.9%
2
Journal of the American Heart Association
119 papers in training set
Top 0.4%
14.0%
3
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.3%
9.8%
4
The American Journal of Cardiology
15 papers in training set
Top 0.2%
9.8%
50% of probability mass above
5
PLOS ONE
4510 papers in training set
Top 33%
4.7%
6
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 0.4%
4.2%
7
Journal of Clinical Medicine
91 papers in training set
Top 1%
3.9%
8
Atherosclerosis
29 papers in training set
Top 0.5%
3.5%
9
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 1%
3.5%
10
International Journal of Cardiology
13 papers in training set
Top 0.2%
3.0%
11
European Heart Journal - Digital Health
15 papers in training set
Top 0.3%
1.8%
12
Journal of the American College of Cardiology
12 papers in training set
Top 0.4%
1.6%
13
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.2%
1.6%
14
Scientific Reports
3102 papers in training set
Top 61%
1.6%
15
Heart
10 papers in training set
Top 0.6%
1.3%
16
BMJ Open
554 papers in training set
Top 10%
1.3%
17
Stroke: Vascular and Interventional Neurology
13 papers in training set
Top 0.3%
0.9%
18
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
0.9%
19
Cardiovascular Research
33 papers in training set
Top 0.8%
0.9%
20
European Journal of Preventive Cardiology
13 papers in training set
Top 0.9%
0.8%
21
Open Heart
19 papers in training set
Top 1%
0.7%
22
PLOS Medicine
98 papers in training set
Top 5%
0.6%